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ABSTRACT
The DNA-dependent protein kinase (DNA-PK) was
identified as an activity and as its three component
polypeptides 25 and 15years ago, respectively. It
has been exhaustively characterized as being abso-
lutely dependent on free double stranded DNA ends
(to which it is directed by its regulatory subunit, Ku)
for its activation as a robust nuclear serine/threo-
nine protein kinase. Here, we report the unexpected
finding of robust DNA-PKcs activation by N-terminal
constraint, independent of either DNA or its regula-
tory subunit Ku. These data suggest that an
N-terminal conformational change (likely induced
by DNA binding) induces enzymatic activation.
INTRODUCTION
The DNA-dependent protein kinase (DNA-PK),
composed of its regulatory subunit (the DNA end
binding factor Ku) and the large catalytic subunit
(DNA-PKcs) initiates the process of ‘classical’ non-
homologous end joining (c-NHEJ) when Ku detects and
binds free DNA ends to which DNA-PKcs then targets
(1–3). Assembly of a Ku molecule and a DNA-PKcs
molecule onto a single DNA end is termed DNA-PK.
Synapses of two DNA-PK complexes provides the
platform for repair which requires appropriate assembly
of c-NHEJ factors (XLF, XRCC4, ligase IV, Artemis)
accessory factors (polm, pol  , PNK), and a growing list
of ‘gluing’ factors and their activators (53BP1, H2AX,
ATM, MRN) that likely stabilize synapsis of the
two broken ends and facilitate repair (4,5). Recent
reports also implicate XRCC4/XLF ﬁlaments in
bridging and stabilizing synapsis of the DNA ends
(S. N. Andres et al., submitted for publication and
S. Roy et al., submitted for publication).
In physiologic salt conditions, DNA-PKcs has no
(or very low) afﬁnity for DNA ends. However, in low
salt conditions, DNA-PKcs binds and is weakly activated
by double stranded DNA ends (6,7). These data suggest a
model whereby DNA binding by DNA-PKcs (facilitated
by Ku) results in activation of DNA-PK’s robust catalytic
activity. Once activated, DNA-PK phosphorylates a
plethora of targets including many of the other factors
in the c-NHEJ pathway, including itself. Although most
c-NHEJ factors are excellent in vitro and in vivo targets of
DNA-PK’s enzymatic activity, DNA-PKcs itself is the
only c-NHEJ factor that has been shown (to date) to be
a functionally relevant (for c-NHEJ) target of its own en-
zymatic activity (8–14). It has been well established that
autophosphorylation on DNA-PK’s catalytic subunit
results in dissociation of DNA-PKcs from the Ku/DNA
end complex (8,15), and considerable effort has been put
forth to deﬁne phosphorylations that mediate kinase dis-
sociation. Our previous studies have shown that two
autophosphorylation site clusters (‘ABCDE’ and ‘PQR’,
located roughly in the middle of the DNA-PKcs polypep-
tide) reciprocally regulate end access during c-NHEJ.
Although phosphorylation within these two clusters regu-
lates end processing, additional phosphorylations
are required to facilitate dissociation of DNA-PKcs
from Ku-bound DNA (9). An additional phosphoryl-
ation site within the putative activation loop in the
C terminal kinase domain regulates kinase activity but
not assembly (10).
Several recent studies ascribe an important role in
kinase activation to the extreme N-terminus of
DNA-PKcs. We have previously identiﬁed two regions
within the N-terminus of DNA-PKcs as being critical
for DNA binding: the leucine rich region (LRR) and the
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tural studies similarly suggest that the extreme N-terminus
may be important for DNA-PKcs interactions with DNA
(17,18). Finally, we have recently characterized four add-
itional phosphorylation sites within the N-terminus of
DNA-PKcs that negatively regulate c-NHEJ (19). Two
of these sites are located at the extreme N-terminus
(S56, S72); phospho-mimicking these sites severely
impairs kinase activation, explaining the negative impact
on c-NHEJ; DNA binding is not impaired by the
phospho-mimicking mutations.
In 1998, Chu and colleagues (20) reported that
DNA-PKcs mediates synapsis of DNA ends and that ac-
tivation of DNA-PK’s enzymatic activity was cooperative,
leading these authors to propose a model whereby DNA
bound by one DNA-PK complex activated the synapsed
opposing complex in trans. We have previously
demonstrated that autophosphorylation within the two
major clusters (ABCDE and PQR) can occur in trans
both in vitro and in living cells, although these experiments
in no way preclude cis autophosphorylations (i.e.
intra-molecular autophosphorylation) at these sites (or
at other phosphorylation sites) occurring as well (21).
Moreover, DNA-PKcs is phosphorylated in living cells
at many additional sites [likely more than 40, (18)]; it
seems quite likely that autophosphorylation of some
sites may occur in cis whereas others occur in trans.I n
fact, recent studies from Lieber and colleagues (22) as well
as Dynan and colleagues (23) using immobilized
antibodies or biotin labeled DNA immobilized by
streptavidin (respectively) are more consistent with a
model whereby DNA-PK is activated (and auto-
phosphorylated) in cis. Although in both studies, care
was taken to make sure that DNA-PKcs was not
saturating, with studies using antibodies, protein G or
streptavidin to immobilize either DNA or DNA-PK,
there is the caveat that multiple DNA-PK molecules
may be co-localized because of the valence of antibodies,
protein G or streptavidin. In sum, there is some discord-
ance in the published literature as to whether DNA-PK
activation results from an interaction of a single DNA-PK
complex with the end of the DNA to which it is bound, or
whether activation of one DNA-PK complex requires
synaptic interaction with the DNA end bound by a
second DNA-PK complex.
In an attempt to address questions of cis as opposed to
trans activation, a variety of tagged DNA-PKcs expres-
sion plasmids were constructed. Although histidine tags
affect the function of DNA-PKcs (whether placed at the
C terminus, N-terminus or at a position internally),
N-terminal GFP and FLAG tagged human DNA-PKcs
fully complement the radiosensitivity of the DNA-PKcs
deﬁcient V3 CHO cell strain. Here we exploit the
mono-valent nature of camelid antibodies (24), to immo-
bilize DNA-PKcs onto agarose beads. We report the un-
expected ﬁnding that N-terminal constraint of DNA-PKcs
(in the absence of Ku or DNA) results in robust kinase
activation. These data suggest a model whereby
an N-terminal conformational change (likely induced by
DNA binding) activates DNA-PK. As discussed earlier,
we have recently shown that phospho-mimicking
(by mutation) two extremely well conserved S/hydropho-
bic sites at the extreme N-terminus of the large DNA-
PKcs polypeptide severely impedes kinase activation
(19). Thus, we suggest that conformational changes at
the extreme N-terminus may explain how DNA-PKcs
‘senses’ DNA and that phosphorylations within this
region regulate kinase activation.
METHODS
Cell culture, expression plasmids and transfectants
Methods to derive V3 transfectants have been described
previously (25). Brieﬂy, cells were cultured in a-MEM
with 10% fetal calf serum, penicillin/streptomycin, and
cipro (complete medium) and maintained at 37C with
5% CO2. N-terminal FLAG tagged and GFP tagged
DNA-PKcs (wild-type) expression plasmids were
described previously (21,26).
Clonogenic survival assays
For zeocin sensitivity, V3 transfectants were cultured in
the indicated dosages of zeocin. After 7 days, cell colonies
were stained with 1% (w/v) crystal violet in ethanol, and
colony numbers were assessed. Survival was plotted as
percentage survival compared to untreated cells.
Immunoprecipitations
Cell pellets (from a conﬂuent 150mm
2 dish) were lysed in
400ml of the following IP buffer: [150mM NaCl, 50mM
Tris, pH 7.5, 1% NP40, 1mM NaFl, 1mM Na3VO4,5 %
glycerol with protease inhibitor tablet added (Pearce,
Rockford, IL, USA)] on ice for 10min, and subsequently
spun in a microcentrifuge at maximum speed for 10min.
Resulting lysate was quantiﬁed and diluted 1:4 with IP
dilution buffer: (150mM NaCl, 50mM Tris, pH 7.5)
and ethidium bromide added to a ﬁnal concentration of
50mg/ml. Diluted lysate (1600ml) was incubated with 50ml
anti-GFP agarose beads (GFP-trap, Allele Biotechnology,
San Diego, CA, USA) rocking, for 1h at 4C. Agarose
beads were washed three times in IP dilution buffer with
protease inhibitors, and then three times in Buffer A:
(25mM HEPES, pH 7.5, 50mM KCl, 10mM MgCl2,
10% glycerol, 1mM EDTA, 1mM EGTA) with
protease inhibitors. Alternatively (Figure 2B),
immunoprecipitations were performed in 50mM HEPES
(pH 7.5), 150mM NaCl, 0.1% Triton X-100, 5mM
MnCl2, 50mM NaFl, 50mg/ml ethidium bromide and
protease inhibitors. This Triton-containing buffer
resulted in more efﬁcient pull-downs. Beads were washed
three times in this buffer, and then three times in Buffer A
(suitable for kinase reactions) as described earlier. Washed
beads were divided into aliquots (generally nine) during
the ﬁnal wash for IP kinase assays.
In some experiments, anti-GFP agarose beads were
produced by ﬁrst synthesizing the cDNA encoding a pub-
lished anti-GFP domain (27) by multiplex PCR using
Phusion DNA polymerase and synthetic oligonucleotides
(DNA sequences available upon request). The resulting
PCR product was subcloned into pCRblunt to generate
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(pET28a-GFP binder). Recombinant camel anti-GFP
was expressed in E. coli and puriﬁed by nickel agarose
afﬁnity, and subsequently covalently coupled to NHS
activated agarose (Thermo Scientiﬁc, Rockford, IL,
USA) according to the manufacturers recommended
protocol.
DNA-PK kinase assays
The DNA-PK enzymatic assay is an adaptation of the
assay originally described by Finnie et al. (28), modiﬁed
by Kienker et al. (29), utilizing a commercially available
DNA-PK assay kit (Promega, Madison, WI, USA). After
extensive washing, aliquots of immunoprecipitates were
incubated in kinase reaction buffer [50mM HEPES
(pH 7.4), 100mM KCl, 10mM MgCl2, 0.1mM EDTA,
0.2mM EGTA, 1mM DTT; 0.1mM ATP, 80mCi/ml
g
32P-ATP and with or without 20mg/ml calf thymus
DNA, 0.8mM biotinylated peptide substrate, 50mg/ml
ethidium bromide as indicated]. For extract kinase reac-
tions, (freeze/thaw) extracts prepared by the method
described by Finnie et al. (28) were prepared in the fol-
lowing buffer (50mM NaF, 20mM HEPES pH 7.8,
450mM NaCl, 25% glycerol, 0.2mM EDTA); 100mg
extract was utilized/reaction. Kinase reactions (25ml)
were incubated for 1h at room temperature and the
reaction stopped by the addition of 10ml 7.5M guanidine
hydrochloride. Ten microliter of each reaction was spotted
onto SAM2 membrane (avidin impregnated membrane;
Promega, Madison, WI, USA); washed extensively in
2M NaCl, and then 2M NaCl in 1% HCPO4. Dried mem-
branes were subjected to scintillation counting. DNA-PK
activity is expressed as fold increase over kinase reactions
with no added peptide (determined for each extract or
IP triplicate). All assays were performed in triplicate.
Experiments presented are representative of no less
than three independent experiments. To detect
autophosphorylated DNA-PKcs, kinase reactions were
stopped by the addition of SDS–PAGE loading buffer;
kinase reactions were electrophoresed, gels dried and sub-
jected to phosphorimaging. To detect phosphorylation of
p53, 2mg puriﬁed recombinant p53 (generous gift Bill
Henry, Michigan State University) was added to kinase
reactions. Kinase reactions were analyzed by SDS–PAGE
as described earlier.
Immunoblotting
Cell extracts or immunoprecipitated fractions were
analyzed after electrophoresis on 4.5% SDS polyacryl-
amide gels and transferred to PVDF membranes. To
detect total DNA-PKcs, a monoclonal antibody raised
against DNA-PKcs (42-27, a generous gift of Dr Tim
Carter, St Johns University, New York, NY, USA) was
used as the primary antibody. Phospho-speciﬁc antibodies
that recognize phosphorylated S2056 (‘R’ site) or T2609
(‘A’ site), (Abcam; Cambridge, MA, USA) were utilized to
detect speciﬁc phosphorylations.
RESULTS
DNA-independent activation of N-terminally constrained
DNA-PKcs
Several strategies were tested for tagging full-length
human DNA-PKcs (Figure 1A) including N-terminal
GFP, FLAG, RFP and HIS as well as C-terminal and
internal HIS tags. Of the seven strategies employed, only
N-terminal GFP and FLAG tagged constructs were able
to completely reverse the radiosensitive phenotype of the
DNA-PKcs deﬁcient cell strain V3 as tested by zeocin sen-
sitivity (a bleomycin analogue that induces double strand
breaks) resistance (Figure 1B); those constructs were
chosen for further study.
A commercially available (Allele Biotech, San Diego,
CA, USA) agarose immobilized camelid antibody was
utilized in immunoprecipitation assays. GFP pull-downs
are remarkably efﬁcient using this reagent. In some experi-
ments, immobilized anti-GFP agarose was produced by
direct coupling of recombinant camel anti-GFP to NHS
agarose as described in the ‘Methods’ section. Immuno-
precipitations were performed either in the presence of
DNA (20mg/ml calf thymus DNA) or ethidium bromide
(50mg/ml) to enhance or block interaction of DNA-PKcs
with Ku bound DNA as has been reported previously
(3,30). As can be seen (Figure 2A), GFP-tagged
wild-type DNA-PKcs is efﬁciently immunoprecipitated
in both conditions. Consistent with previous studies,
DNA-PKcs only co-immunoprecipitates with Ku in the
presence of DNA (3,30).
Figure 1. N-terminally GFP-tagged DNA-PKcs reverses V3’s
radiosensitive phenotype. (A) Diagram of DNA-PKcs coding
sequence showing position of HIS, GFP, FLAG and RFP tags pos-
itioned in this study. Asterisks denote positions of previously studied
phosphorylation sites. (B) V3 transfectants expressing either wild-type
DNA-PKcs, or the GFP-tagged wild-type DNA-PKcs, or no
DNA-PKcs were plated into complete media with increasing doses of
zeocin as indicated at cloning densities. Colonies were stained after 7
days later and percent survival was calculated. Error bars represent
SEM.
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tinylated p53 peptide spanning its well studied
N-terminal SQ DNA-PK target site (S15) was assessed
in whole V3 cell extracts or in immunoprecipitates
performed in the presence of 50mg/ml ethidium bromide
(immunoprecipitates were washed extensively to remove
ethidium bromide prior to enzymatic assays). The kin-
ase assay utilized is a modiﬁcation of the DNA cellulose
‘pull-down’ assay described previously (29). In this assay,
extracts or immunoprecipitates are incubated in the pres-
ence or absence of a biotinylated p53 peptide spanning the
S15 phosphorylation site. The phosphorylated peptide is
then captured onto a biotin-coated membrane; after exten-
sive washing, bound phosphorylated peptide is assessed by
scintillation counting. Enzymatic activity is expressed as
fold increase over no peptide control reactions (performed
for each extract or immunoprecipitate). As expected,
phosphorylation of the p53 peptide when measured in
extracts is highly dependent on DNA. In the extract
kinase assays, addition of ethidium bromide (which
disrupts Ku-DNA interaction) completely ablates
phosphorylation in the presence of DNA. This demon-
strates that the concentration of ethidium bromide
utilized here and in all subsequent experiments is sufﬁcient
to completely abrogate kinase activation. Further, this
level of ethidium bromide also suppresses the minimal
phosphorylation observed in extracts without additional
DNA added (this phosphorylation is presumably the
result of DNA contamination in whole cell extracts).
The GFP immunoprecipitates efﬁciently phosphorylated
the p53 peptide, but to our surprise, the addition of
DNA, ethidium bromide or recombinant Ku plus DNA
(not shown) had no affect on the robust peptide phosphor-
ylation observed in the anti-GFP pull-down fractions.
Since DNA-independent enzymatic activity of
DNA-PK has not been reported in physiologic kinase
conditions, we considered that a contaminating kinase
with activity towards the p53 peptide was responsible for
the observed activity. Similar paired extract and
pull-down kinase assays were performed with extracts
derived from cells expressing GFP wild-type, GFP-
kinase inactive and FLAG wild-type DNA-PKcs con-
structs (Figure 3A). We have described previously a Lys
to Arg mutant at amino acid 3752 (K3752R) that was
designed to disrupt ATP-binding (29,31), although the
precise ATP-binding site has not been determined in
DNA-PKcs. As expected, phosphorylation of the p53
peptide when measured in extracts containing either
FLAG or GFP-tagged wild-type DNA-PKcs is highly de-
pendent on DNA; further, no DNA-dependent phosphor-
ylation was observed in extracts containing catalytically
inactive GFP-tagged DNA-PKcs. However, phosphoryl-
ation of the p53 target peptide was observed in
immunoprecipitated FLAG or GFP-tagged DNA-PKcs
extracts. This activity was not affected by the addition
of either DNA or ethidium bromide, and the activity
was not observed in immunoprecipitates of GFP-tagged
kinase inactive DNA-PKcs. Immunoblotting revealed
similar levels of immunoprecipitated DNA-PKcs from
each extract as well as the absence of Ku. Several add-
itional IP kinase experiment were performed using the
GFP reagent as well as a well-studied anti-DNA-PKcs
monoclonal antibody (42-27, immobilized by protein G
sepharose) that recognizes a determinant in the
C-terminal 150kD of the DNA-PKcs polypeptide. Since
retrieval of DNA-PKcs with the anti-DNA-PKcs was not
as efﬁcient as with the anti-GFP reagent, a titration of
different extract concentrations was immobilized with
the anti-GFP reagent (Figure 3B). As can be seen, more
DNA-PK activity is retrieved in anti-GFP pull-downs as
extract concentration is increased. No signiﬁcant
DNA-PK activity was observed in pull down fractions
using the anti-DNA-PKcs antibody, although retrieval
of DNA-PKcs was similar to that retrieved using the
anti-GFP reagent and approximately one-half as much
extract. These data suggest that immobilizing
DNA-PKcs via its N-terminus (by antibodies to either
FLAG or GFP N-terminal tags) results in robust phos-
phorylation of the S15 p53 peptide target.
In the titration experiment, (at higher concentrations of
extract) DNA-PK activity did not double when extract
concentration was doubled, and we considered that the
Figure 2. DNA-independent activation of N-terminally constrained
DNA-PKcs. (A) Whole cell extracts or anti-GFP immunoprecipitates
in the presence or absence of DNA (20mg/ml) or ethidium bromide
(50mg/ml) as indicated from V3 transfectants expressing GFP-tagged
wild-type DNA-PKcs were analyzed by immunoblotting using anti-
DNA-PKcs or anti-Ku antibodies as indicated. (B) DNA-PK enzymatic
levels were determined in extracts or anti-GFP immunoprecipitates
from V3 transfectants expressing GFP-tagged wild-type DNA-PKcs
in the presence or absence of DNA (20mg/ml), or ethidium bromide
50mg/ml). Relative activity is depicted as fold-increase over no peptide
as described in the ‘Methods’ section. Error bars depict SDs of tripli-
cate assays. This assay is representative of no less than three independ-
ent assays.
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relative DNA-PK activity of GFP-tagged DNA-PKcs
immobilized on anti-GFP agarose was compared to
increasing levels of a commercial preparation of puriﬁed
human DNA-PKcs (Promega, Madison, WI, USA). As
can be seen (Figure 3C), the amount of activity retrieved
by anti-GFP IP of 20mg of V3 transfectant extract is
similar to the activity of 100U of the commercial
Figure 3. DNA-independent activation of N-terminally constrained DNA-PKcs. (A, left panel) DNA-PK enzymatic levels were determined in
extracts, anti-GFP immunoprecipitates or anti-FLAG immunoprecipitates from V3 transfectants expressing GFP-tagged wild-type DNA-PKcs or
FLAG-tagged wild-type DNA-PKcs, or GFP-tagged catalytically inactive mutant DNA-PKcs, K3752R (as indicated) in the presence or absence of
DNA (20mg/ml), or ethidium bromide 50mg/ml). Relative activity is depicted as fold-increase over no peptide as described in the ‘Methods’ section.
Error bars depict SDs of triplicate assays. This assay is representative of no less than three independent assays. (A, right panel) Whole cell extracts
(e), anti-GFP or anti-FLAG immunoprecipitates (p) from V3 transfectants expressing GFP-tagged or FLAG-tagged wild-type DNA-PKcs or
GFP-tagged catalytically inactive mutant K3752R were analyzed by immunoblotting using anti-DNA-PKcs or anti-Ku antibodies as indicated.
(B, left panel) DNA-PK enzymatic levels were determined in extracts, anti-GFP immunoprecipitates (1X=2.5mg extract. 2X=5mg extract.
4X=10mg extract. 8X=20mg extract) or anti-DNA-PKcs immunoprecipitates (20mg extract, using mAB 42-27) from V3 transfectants expressing
GFP-tagged wild-type DNA-PKcs in the presence or absence of DNA (20mg/ml), or ethidium bromide 50mg/ml). Relative activity is depicted as
fold-increase over no peptide as described in the ‘Methods’ section. Error bars depict SDs of triplicate assays. This assay is representative of no less
than three independent assays. (B, right panel) Immunoblotting of IP fractions probed with anti-DNA-PKcs antibody. (C, left panel) DNA-PK
enzymatic levels were determined from anti-GFP immunoprecipitates, GFP-tagged catalytically inactive mutant DNA-PKcs, K3752R (as indicated),
or 100 or 400U puriﬁed DNA-PK in the presence or absence of DNA (20mg/ml), or ethidium bromide 50mg/ml). Relative activity is depicted as
fold-increase over no peptide as described in the ‘Methods’ section. Error bars depict SDs of triplicate assays. This assay is representative of no less
than three independent assays. (C, right panel) Anti-GFP immunoprecipitates from V3 transfectants expressing GFP-tagged wild-type DNA-PKcs,
GFP-tagged catalytically inactive mutant K3752R, or vector alone were analyzed by silver staining and compared to 100U puriﬁed DNA-PK.
2968 Nucleic Acids Research, 2012,Vol.40, No. 7preparation, whereas substantially higher activity (3-fold
more) is observed in assays utilizing 400U.
Ku independent activation of N-terminally constrained
DNA-PKcs
To further conﬁrm that the observed enzymatic activity
represented DNA and Ku independent phosphorylation
by DNA-PKcs, GFP-tagged DNA-PKcs was expressed
in xrs6 cells that lack Ku (Figure 4). As can be seen,
stable transfection of the GFP-tagged wild-type
DNA-PKcs expression vector in xrs6 cells markedly in-
creases DNA-PKcs expression compared to the level of
endogenous hamster DNA-PKcs (Figure 4A). Although
DNA-dependent p53 phosphorylation is readily detected
in V3 extracts over-expressing GFP-tagged human
DNA-PKcs (as in Figure 2), no activity is detected in
xrs6 extracts from cells over-expressing GFP-tagged
human DNA-PKcs (since these cells lack Ku86).
However, robust, DNA-independent activity is detected
in GFP immunoprecipitates of both V3 and xrs6 cells ex-
pressing GFP-DNA-PKcs but not vector controls. These
data are consistent with DNA and Ku independent acti-
vation of DNA-PKcs tethered by its N-terminus.
DNA-PKcs can be activated by N-terminal constraint in
physiologic salt
As discussed earlier, DNA-PKcs has no (or very low)
afﬁnity for DNA ends in physiologic salt conditions (6,7).
However, in low salt conditions (less than 50mM),
DNA-PKcs binds and is weakly activated by double
stranded DNA ends. Although immunoprecipitations are
performed in buffer containing 150mM NaCl, the buffer
is exchanged to a standard kinase buffer during washing.
The kinase buffer utilized includes 100mM KCl, 50mM
HEPES (pH 7.5), 10mM MgCl2, but lacks NaCl. We next
determined whether DNA-PK activated by N-terminal
constraint was salt labile. As can be seen (Figure 5),
there is no signiﬁcant reduction of kinase activity by the
addition of 50mM or 100mM NaCl. Hammarstan and
Chu (6) reported virtually no DNA-PKcs activity
(without Ku) in 100mM NaCl, and West et al. (7)
reported a 3-fold reduction in activity in 100mM
compared to 50mM NaCl. The modest reduction in en-
zymatic activity observed in Figure 5 does not approach
the level of reduction observed by others for DNA-
dependent activation of isolated DNA-PKcs (i.e. without
Ku), and we conclude that the activity described here re-
sembles authentic DNA-PK activity (i.e. that ascribed to
DNA-PKcs+Ku) with regards to its salt lability.
DNA-independent autophosphorylation of N-terminally
constrained DNA-PKcs
We next determined whether DNA-PKcs auto-
phosphorylation occurs under these activation conditions.
In an effort to match DNA-PKcs concentrations, in vitro
kinase reactions were performed with different amounts of
immobilized GFP-DNA-PKcs and different amount of
the puriﬁed enzyme preparation; kinase assays were
electrophoresed on 4.5% SDS–PAGE gels and
32P incorp-
oration assessed by phosphorimager. As can be seen
(Figure 6), autophosphorylation of DNA-PKcs is DNA
dependent in assays utilizing puriﬁed enzyme but DNA
independent in assays using immobilized GFP-
DNA-PKcs. Autophosphorylation was also assessed by
immunoblotting with a phospho-speciﬁc antibodies that
recognizes phosphorylated S2056 (‘R’ site in the PQR
cluster) and T2609 (‘A’ site in ABCDE cluster). S2056
Figure 4. Ku independent activation of N-terminally constrained
DNA-PKcs. (A) Whole cell extracts from V3 or xrs-6 cells expressing
wt-GFP tagged DNA-PKcs or vector only were analyzed by immuno-
blotting using anti-DNA-PKcs antibody, 42-27. (B) DNA-PK enzym-
atic levels were determined in extracts or anti-GFP immunoprecipitates
from V3 transfectants expressing GFP-tagged wild-type DNA-PKcs or
xrs6 transfectants expressing wilt type GFP-tagged wild-type DNA-
PKcs or vector alone xrs6 transfectants (as indicated) in the presence
or absence of DNA (20mg/ml), or ethidium bromide 50mg/ml). Relative
activity is depicted as fold-increase over no peptide as described in the
‘Methods’ section. Error bars depict SDs of triplicate assays. This assay
is representative of no less than three independent assays.
Figure 5. DNA-PKcs can be activated by N-terminal constraint in
physiologic salt. DNA-PK enzymatic levels were determined in
anti-GFP immunoprecipitates from V3 transfectants expressing
GFP-tagged wild-type DNA-PKcs in the presence of DNA (20mg/ml)
and no salt, 50mM NaCl, or 100mM NaCl as indicated. Relative
activity is depicted as fold-increase over no peptide as described in
the ‘Methods’ section. Error bars depict SDs of triplicate assays. This
assay is representative of no less than three independent assays.
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even though P-32 incorporation is similar in both
pull-down assays and assays using puriﬁed enzyme. We
have previously shown that both S2056 and T2609 phos-
phorylations can occur in trans both in vitro and in living
cells. However detection of autophosphorylation of DNA-
PKcs that is immobilized by a monovalent reagent (both
by P-32 incorporation and by phospho-speciﬁc antibodies)
suggests a single DNA-PKcs molecule can auto-
phosphorylate itself.
DNA-PKcs activated by N-terminal constraint
phosphorylates full length p53, albeit less efﬁciently than
DNA activated DNA-PK
To determine whether the observed enzymatic activity was
active towards other well-studied DNA-PK targets, kinase
assays were done in the presence of recombinant p53. In
these experiments, we compared phosphorylation of re-
combinant p53 by either immunoprecipitated GFP-
DNA-PKcs or puriﬁed DNA-PK (Promega, Madison,
WI, USA). Phosphorylation of p53 (Figure 7) by
puriﬁed DNA-PK is robust and DNA dependent as
expected. In contrast, p53 is phosphorylated by immuno-
precipitated DNA-PKcs in the presence or absence of
DNA or ethidium bromide. The enzymatic activity
towards recombinant full length p53 by immobilized
DNA-PKcs is considerably less than the activity of
DNA-PK in solution; however, in the same reactions,
autophosphorylation of immobilized GFP-DNA-PKcs is
more robust than that of 100U puriﬁed DNA-PK. Peptide
assays were performed concurrently; enzymatic activity of
GFP-DNA-PKcs was similar to 100U puriﬁed enzyme;
whereas activity from 400U was 5-fold higher. We
conclude that DNA-PKcs tethered by its N-terminus is
constitutively active towards a variety of known DNA-
PK targets, although its autophosphorylation and
peptide phosphorylations are more efﬁcient when the
enzyme is immobilized, whereas phosphorylation of full
length p53 is less efﬁcient when the enzyme is immobilized.
N-terminal tethering cannot rescue enzymatic activity in
N-terminal phospho-mimics at sites that regulate kinase
activity
Recently we have reported mutational studies of several
additional phosphorylation sites within DNA-PKcs (19).
Brieﬂy, earlier work from our laboratory demonstrated
that DNA-PKcs with 13 S/T to A substitutions of previ-
ously studied autophosphorylation sites still undergoes
autophosphorylation induced kinase dissociation at rates
similar to the wild-type kinase (10). Since, we had also
shown that the extreme N-terminus (N-terminal 426
amino acids) and the Leucine Rich Region contribute to
the stability of the DNA-PK complex (10,16), we reasoned
that phosphorylation within regions important for
complex assembly might mediate kinase dissociation.
Examination of these regions for potential target sites
revealed two highly conserved potential DNA-PKcs
autophosphorylation sites, S-hydrophobic 56–57 (‘N1’)
and S-hydrophobic 72–73 (‘N2’). N1 (S56) is present in
every DNA-PKcs sequence available; the N2 target (S72)
is also present in every species although the adjacent
hydrophobic site is not conserved in slime mold.
Previously, these sites were studied as combined S/T to
D or S/T to A mutants (19). Although, the combined S/
T to A mutant completely restores radioresistance to V3
cells, the S/T to D mutant completely fails to complement
V3’s radiosensitive phenotype. This can be attributed to
markedly reduced catalytic activity of the S/T to D
phospho-mimic, which can only be demonstrated
using DNA-cellulose pull-down assays. The S/T to D
Figure 6. DNA-independent autophosphorylation of N-terminally con-
strained DNA-PKcs. Phosphorimager analysis of kinase reactions
electrophoresed in 4.5% SDS–PAGE anti-GFP immunoprecipitates or
puriﬁed DNA-PK (as indicated) in the presence or absence of DNA
(20mg/ml), or ethidium bromide 50mg/ml). (A) phosphorimager
analysis; (B) immunoblot with anti-DNA-PKcs antibody 42-27;
(C) immunoblot analysis with pS2056; (D) immunoblot analysis with
pT2609.
Figure 7. DNA-PKcs activated by N-terminal constraint phosphoryl-
ates p53, albeit slightly less efﬁciently than DNA activated DNA-PK.
Phosphorimager analysis of kinase reactions electrophoresed in 7%
SDS–PAGE using puriﬁed DNA-PK or anti-GFP immunoprecipitates
(as indicated) to phosphorylate recombinant p53 in the presence or
absence of DNA (20mg/ml), or ethidium bromide (50mg/ml).
2970 Nucleic Acids Research, 2012,Vol.40, No. 7phospho-mimic associates with Ku-bound DNA and with
chromosomalDSBsinlivingcellsasevidencedbyitsability
to robustly inhibit homologous recombination mediated
repair of chromosomal DSBs. This is the ﬁrst mutation in
DNA-PK outside of the PI3 kinase domain or extreme C
terminus that affects enzymatic activity. The extreme
phenotype observed by phospho-mimicking these ex-
tremely well conserved ‘N1 and N2’ sites are consistent
with a model whereby N1 and N2 sites phosphorylation
interferes with the interaction of DNA-PKcs with DNA,
abrogating kinase activation. A proposed model of
DNA-PKcs is depicted in Figure 8A. It is thought that
the N-terminal ‘pincers’ (the green arms correspond to
the N-terminal HEAT repeat regions) may tighten
when DNA threads between the two pincers into a
putative DNA binding pocket (shown in pink). The
position of the extreme N-terminus is shown in
yellow. Phosphorylation of sites in this area may inter-
fere with how DNA interacts with the pincer
domains. Similar, immobilization by tags attached to the
N-termini might also affect how the pincer domains can
interact with DNA.
To ascertain whether N-terminal tethering can relieve
negative impact of phospho-mimicking the N sites, a
GFP-tagged construct with the above-mentioned
combined S/T to D mutations was generated and
expressed in V3 cells. Although expressed at similar
levels as GFP-tagged wild-type DNA-PKcs, the GFP-
tagged combined S/T to D mutant does not complement
V3’s radiosensitive phenotype (Figure 8B) consistent with
lack of complementation with the un-tagged mutant (19).
Paired IP and extract kinase assays were done with
extracts from V3 cells expressing wt-GFP tagged,
K3752R-GFP tagged and combined S/T to D GFP
tagged DNA-PKcs. As can be seen (Figure 8C), only
minimal enzymatic activity is demonstrable in pull-downs
of the combined S/T to D GFP mutant [consistent with
DNA cellulose pull-downs in our previous study (19)].
However, the activity is DNA independent. We conclude
that N-terminal tethering cannot relieve the negative
impact of phospho-mimicking of S52/S72. These data
are consistent with a model whereby DNA binding
results in a conformational change at the extreme
N-terminus that allows DNA-PKcs to ‘sense’ DNA;
moreover, phosphorylations within this region abate
kinase activation.
DISCUSSION
Experiments presented here were designed to address cis
versus trans activation. Although activation in this artiﬁ-
cial system occurs in cis, this N-terminal constraint likely
mimics DNA binding induced conformation change.
Thus, our work does not clarify the discordant published
conclusions of whether DNA-PK is activated by
DNA bound in cis versus trans. However, these data
do provide additional insight into whether auto-
phosphorylation occurs in cis or trans.
We have previously demonstrated (by using site ablated
mutants to phosphorylate a kinase inactive molecule) that
Figure 8. Two highly conserved S/hydrophobic sites at the extreme
N-terminus regulate kinase activation. (A) Cartoon depiction of
DNA-PKcs. N-terminal pincer domains are shown in green. The
extreme N-terminus is shown in yellow, presumable position of ‘N’
phosphorylation sites. The C-terminal ‘head’ domain that includes the
catalytic domain is shown in red. A putative DNA binding pocket has
been proposed and is shown in pink. (B) V3 transfectants expressing
either GFP-tagged wild-type DNA-PKcs, GFP-tagged combined S/T to
D mutant DNA-PKcs (N>D), or no DNA-PKcs were plated into
complete media with increasing doses of zeocin as indicated at
cloning densities. Colonies were stained after 7 days later and percent
survival was calculated. Error bars represent SEM. Left panel
depicts immunoblot analyses of DNA-PKcs expression in extracts
from V3 cells expressing GFP-tagged wild-type DNA-PKcs,
GFP-tagged combined S/T to D mutant DNA-PKcs, or no
DNA-PKcs. (C) DNA-PK enzymatic levels were determined in
extracts or anti-GFP immunoprecipitates from V3 transfectants
expressing GFP-tagged wild-type (wt-g), GFP-tagged K3752R
mutant (K>Rg) or GFP-tagged combined S/T to D mutant
DNA-PKcs (N>Dg) in the presence or absence of DNA (20mg/
ml). Relative activity is depicted as fold-increase over no peptide
as described in the ‘Methods’ section. Error bars depict SDs of tripli-
cate assays. This assay is representative of no less than three independ-
ent assays. To illustrate minimal activity present in GFP-N>D mutant
IP kinase reactions, grey line shows level for no enzymatic activ-
ity (1=fold over no peptide control).
Nucleic Acids Research,2012, Vol.40, No. 7 2971phosphorylation of the ABCDE and PQR sites can occur
in trans both in vitro and in living cells. The experiments
presented here showing autophosphorylation of DNA-
PKcs molecules immobilized by a monovalent reagent
on an 80 micron agarose bead suggest that cis
autophosphorylation can also occur, a conclusion also
reached by Lieber and colleagues working with multiva-
lent immobilization techniques.
The DNA dependence of DNA-PK has been studied for
decades. It has been proposed that Ku undergoes a con-
formational change when bound to DNA that allows
DNA-PKcs to interact with both Ku and the DNA end
(7). The interaction of DNA-PKcs with the DNA end
(bound by Ku) or with the DNA alone (in low salt con-
ditions), results in enzymatic activation. Here, we report
the unexpected ﬁnding of robust DNA-PKcs activation by
N-terminal constraint, independent of either DNA or its
regulatory subunit Ku. These data suggest that immobil-
ization of the extreme N-terminus mimics DNA binding;
thus, we suggest that an N-terminal conformational
change (likely induced by DNA binding) actually
induces enzymatic activation. Consistent with this model
ascribing a critical role for the N-terminus in kinase
activation, recent studies from our laboratories demon-
strate that phosphorylation at two conserved sites at the
extreme N-terminus of DNA-PKcs affects the ability of
the kinase to be activated (19). Thus, phosphorylation at
the extreme N-terminus (at S56/S72) may preclude the
N-terminal conformational change required to activate
DNA-PK.
The low-resolution structure of DNA-PKcs in complex
with the CTR of Ku80 reveals a horseshoe or pincer
shaped molecule in which the large N-terminal domain
forms two arms that surround a central open cavity that
is suggested to bind dsDNA, while the FAT-kinase-
FAT-C domain of DNA-PKcs resides at the apex of the
structure (Figure 8A) (32). The region at the top of the
arms is predicted to undergo conformational ﬂexibility,
which may account for autophosphorylation induced con-
formational changes in DNA-PKcs (18). Interestingly, the
two arms do not meet at the base of the molecule, creating
a gap, and we have suggested that conformational changes
for example in the ﬂexible regions at the apex of the arms
may cause opening and closing of the gap and thus
regulate interaction of the central cavity with DNA.
Thus, DNA-PKcs is predicted to be a highly dynamic
molecule that undergoes considerable conformational
plasticity that is regulated at least in part by phosphoryl-
ation (18). Moreover, the N-terminus of DNA-PKcs is
predicted to be located close to the gap at the base of
the structure (32), thus phosphorylation at N-terminal
regions of DNA-PKcs (for example at S56 and S72)
might also induce conformational changes, causing
opening and closing of the gap and regulating interactions
with DNA.
In sum, our data suggest that conformational changes
in the N-terminus of DNA-PKcs (likely induced by DNA
binding) enable DNA-PK to ‘sense’ DNA binding which
is then communicated to the kinase domain resulting in
enzyme activation.
FUNDING
Public Health Service (Grant AI048758 to K.M.),
Association for International Cancer Research (Grant
09-0633 to M.M.) and Association pour la Recherche
contre le Cancer (Grant A09/2/5075 to M.M.). Funding
for open access charge: Public Health Service (grant
AI048758).
Conﬂict of interest statement. None declared.
REFERENCES
1. Walker,A.I., Hunt,T., Jackson,R.J. and Anderson,C.W. (1985)
Double-stranded DNA induces the phosphorylation of several
proteins including the 90000 mol. wt. heat-shock protein in
animal cell extracts. EMBO J., 4, 139–145.
2. Hartley,K.O., Gell,D., Smith,G.C., Zhang,H., Divecha,N.,
Connelly,M.A., Admon,A., Lees-Miller,S.P., Anderson,C.W. and
Jackson,S.P. (1995) DNA-dependent protein kinase catalytic
subunit: a relative of phosphatidylinositol 3-kinase and the ataxia
telangiectasia gene product. Cell, 82, 849–856.
3. Gottlieb,T.M. and Jackson,S.P. (1993) The DNA-dependent
protein kinase: requirement for DNA ends and association with
Ku antigen. Cell, 72, 131–142.
4. Lieber,M.R. (2010) The mechanism of double-strand DNA break
repair by the nonhomologous DNA end-joining pathway.
Annu. Rev. Biochem., 79, 181–211.
5. Mahaney,B.L., Meek,K. and Lees-Miller,S.P. (2009) Repair of
ionizing radiation-induced DNA double-strand breaks by
non-homologous end-joining. Biochem. J., 417, 639–650.
6. Hammarsten,O. and Chu,G. (1998) DNA-dependent protein
kinase: DNA binding and activation in the absence of Ku.
Proc. Natl. Acad. Sci. USA, 95, 525–530.
7. West,R.B., Yaneva,M. and Lieber,M.R. (1998) Productive and
nonproductive complexes of Ku and DNA-dependent protein
kinase at DNA termini. Mol. Cell. Biol., 18, 5908–5920.
8. Block,W.D., Yu,Y., Merkle,D., Gifford,J.L., Ding,Q., Meek,K.
and Lees-Miller,S.P. (2004) Autophosphorylation-dependent
remodeling of the DNA-dependent protein kinase catalytic
subunit regulates ligation of DNA ends. Nucleic Acids Res., 32,
4351–4357.
9. Cui,X., Yu,Y., Gupta,S., Cho,Y.M., Lees-Miller,S.P. and
Meek,K. (2005) Autophosphorylation of DNA-dependent protein
kinase regulates DNA end processing and may also alter
double-strand break repair pathway choice. Mol. Cell. Biol., 25,
10842–10852.
10. Douglas,P., Cui,X., Block,W.D., Yu,Y., Gupta,S., Ding,Q.,
Ye,R., Morrice,N., Lees-Miller,S.P. and Meek,K. (2007) The
DNA-dependent protein kinase catalytic subunit is
phosphorylated in vivo on threonine 3950, a highly conserved
amino acid in the protein kinase domain. Mol. Cell. Biol., 27,
1581–1591.
11. Douglas,P., Gupta,S., Morrice,N., Meek,K. and Lees-Miller,S.P.
(2005) DNA-PK-dependent phosphorylation of Ku70/80 is not
required for non-homologous end joining. DNA Repair, 4,
1006–1018.
12. Goodarzi,A.A., Yu,Y., Riballo,E., Douglas,P., Walker,S.A.,
Ye,R., Harer,C., Marchetti,C., Morrice,N., Jeggo,P.A. et al.
(2006) DNA-PK autophosphorylation facilitates Artemis
endonuclease activity. EMBO J., 25, 3880–3889.
13. Yu,Y., Mahaney,B.L., Yano,K., Ye,R., Fang,S., Douglas,P.,
Chen,D.J. and Lees-Miller,S.P. (2008) DNA-PK and ATM
phosphorylation sites in XLF/Cernunnos are not required for
repair of DNA double strand breaks. DNA Repair, 7, 1680–1692.
14. Yu,Y., Wang,W., Ding,Q., Ye,R., Chen,D., Merkle,D.,
Schriemer,D., Meek,K. and Lees-Miller,S.P. (2003) DNA-PK
phosphorylation sites in XRCC4 are not required for survival
after radiation or for V(D)J recombination. DNA Repair, 2,
1239–1252.
2972 Nucleic Acids Research, 2012,Vol.40, No. 715. Chan,D.W. and Lees-Miller,S.P. (1996) The DNA-dependent
protein kinase is inactivated by autophosphorylation of the
catalytic subunit. J. Biol. Chem., 271, 8936–8941.
16. Gupta,S. and Meek,K. (2005) The leucine rich region of
DNA-PKcs contributes to its innate DNA afﬁnity.
Nucleic Acids Res., 33, 6972–6981.
17. Hammel,M., Yu,Y., Mahaney,B.L., Cai,B., Ye,R., Phipps,B.M.,
Rambo,R.P., Hura,G.L., Pelikan,M., So,S. et al. (2010) Ku and
DNA-dependent protein kinase dynamic conformations and
assembly regulate DNA binding and the initial non-homologous
end joining complex. J. Biol. Chem., 285, 1414–1423.
18. Dobbs,T.A., Tainer,J.A. and Lees-Miller,S.P. (2010) A structural
model for regulation of NHEJ by DNA-PKcs
autophosphorylation. DNA Repair, 9, 1307–1314.
19. Neal,J.A., Dang,V., Douglas,P., Wold,M.S., Lees-Miller,S.P. and
Meek,K. (2011) Inhibition of HR by DNA-PK requires kinase
activity, is titratable, and is modulated by autophosphorylation.
Mol. Cell. Biol, 31, 1719–1733.
20. DeFazio,L.G., Stansel,R.M., Grifﬁth,J.D. and Chu,G. (2002)
Synapsis of DNA ends by DNA-dependent protein kinase.
EMBO J., 21, 3192–3200.
21. Meek,K., Douglas,P., Cui,X., Ding,Q. and Lees-Miller,S.P. (2007)
trans Autophosphorylation at DNA-dependent protein
kinase’s two major autophosphorylation site clusters facilitates
end processing but not end joining. Mol. Cell. Biol., 27,
3881–3890.
22. Lu,H., Shimazaki,N., Raval,P., Gu,J., Watanabe,G., Schwarz,K.,
Swanson,P.C. and Lieber,M.R. (2008) A biochemically deﬁned
system for coding joint formation in V(D)J recombination.
Mol. Cell., 31, 485–497.
23. Jovanovic,M. and Dynan,W.S. (2006) Terminal DNA structure
and ATP inﬂuence binding parameters of the DNA-dependent
protein kinase at an early step prior to DNA synapsis.
Nucleic Acids Res., 34, 1112–1120.
24. Muyldermans,S. (2001) Single domain camel antibodies: current
status. J. Biotechnol., 74, 277–302.
25. Ding,Q., Reddy,Y.V., Wang,W., Woods,T., Douglas,P.,
Ramsden,D.A., Lees-Miller,S.P. and Meek,K. (2003)
Autophosphorylation of the catalytic subunit of the
DNA-dependent protein kinase is required for efﬁcient end
processing during DNA double-strand break repair.
Mol. Cell. Biol., 23, 5836–5848.
26. Convery,E., Shin,E.K., Ding,Q., Wang,W., Douglas,P.,
Davis,L.S., Nickoloff,J.A., Lees-Miller,S.P. and Meek,K. (2005)
Inhibition of homologous recombination by variants of the
catalytic subunit of the DNA-dependent protein kinase
(DNA-PKcs). Proc. Natl Acad. Sci. USA, 102, 1345–1350.
27. Kirchhofer,A., Helma,J., Schmidthals,K., Frauer,C., Cui,S.,
Karcher,A., Pellis,M., Muyldermans,S., Casas-Delucchi,C.S.,
Cardoso,M.C. et al. Modulation of protein properties in living
cells using nanobodies. Nat. Struct. Mol. Biol., 17, 133–138.
28. Finnie,N.J., Gottlieb,T.M., Blunt,T., Jeggo,P.A. and Jackson,S.P.
(1995) DNA-dependent protein kinase activity is absent in xrs-6
cells: implications for site-speciﬁc recombination and DNA
double-strand break repair. Proc. Natl Acad. Sci. USA, 92,
320–324.
29. Kienker,L.J., Shin,E.K. and Meek,K. (2000) Both V(D)J
recombination and radioresistance require DNA-PK kinase
activity, though minimal levels sufﬁce for V(D)J recombination.
Nucleic Acids Res., 28, 2752–2761.
30. Chan,D.W., Mody,C.H., Ting,N.S. and Lees-Miller,S.P. (1996)
Puriﬁcation and characterization of the double-stranded
DNA-activated protein kinase, DNA-PK, from human placenta.
Biochem. Cell. Biol., 74, 67–73.
31. Kurimasa,A., Kumano,S., Boubnov,N.V., Story,M.D., Tung,C.S.,
Peterson,S.R. and Chen,D.J. (1999) Requirement for the kinase
activity of human DNA-dependent protein kinase catalytic
subunit in DNA strand break rejoining. Mol. Cell. Biol., 19,
3877–3884.
32. Sibanda,B.L., Chirgadze,D.Y. and Blundell,T.L. (2010)
Crystal structure of DNA-PKcs reveals a large open-ring
cradle comprised of HEAT repeats. Nature, 463, 118–121.
Nucleic Acids Research,2012, Vol.40, No. 7 2973